Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant
Dexamethasone is widely used in preterm infants with severe pulmonary disease. Hypertrophic cardiomyopathy (HCM) is a transient side effect observed after multiple doses of dexamethasone. We report a preterm infant with myocardial hypertrophy after a single dose of dexamethasone (0.5 mg/kg) used to...
Main Authors: | Yusuf Kale, Ozge Aydemir, Ozben Ceylan, Ahmet Yagmur Bas, Nihal Demirel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-08-01
|
Series: | Pediatrics and Neonatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957213000673 |
Similar Items
-
Hypertrophic Cardiomyopathy : A Practical Guide to Diagnosis and Management /
by: Adhyapak, Srilakshmi M., editor 635827, et al.
Published: (2021) -
Apical Hypertrophic Cardiomyopathy: A Special Entity.
by: Ajay Adhikaree, et al.
Published: (2020-01-01) -
Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features
by: Lanyan Guo, et al.
Published: (2023-08-01) -
Hypertrophic cardiomyopathy
by: Sarita Gore, et al.
Published: (2022-01-01) -
Clinical presentation and long‐term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study
by: Gabrielle Norrish, et al.
Published: (2021-12-01)